Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease.

[1]  Z. A. Bhat,et al.  Advances in Herbal Medicine for Treatment of Ischemic Brain Injury , 2014, Natural product communications.

[2]  Leonardo Pardo,et al.  Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease. , 2014, Journal of medicinal chemistry.

[3]  P. Bai,et al.  Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease. , 2014, European journal of medicinal chemistry.

[4]  Sanghyun Lee,et al.  Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease. , 2014, Journal of the American Chemical Society.

[5]  Zhenghuai Tan,et al.  Synthesis of pterostilbene and resveratrol carbamate derivatives as potential dual cholinesterase inhibitors and neuroprotective agents , 2014, Research on Chemical Intermediates.

[6]  Xingshu Li,et al.  Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity. , 2013, Bioorganic & medicinal chemistry letters.

[7]  Ying Guo,et al.  Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury. , 2013, Bioorganic & medicinal chemistry.

[8]  Hai-bin Luo,et al.  Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease. , 2013, Journal of medicinal chemistry.

[9]  Z. Guan,et al.  The neurotoxicity of β-amyloid peptide toward rat brain is associated with enhanced oxidative stress, inflammation and apoptosis, all of which can be attenuated by scutellarin. , 2013, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[10]  José Marco-Contelles,et al.  Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease , 2013, Medicinal research reviews.

[11]  I. Ginsburg,et al.  Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease. , 2012, Journal of medicinal chemistry.

[12]  Yuping Tang,et al.  Synthesis and Protective Effect of Scutellarein on Focal Cerebral Ischemia/Reperfusion in Rats , 2012, Molecules.

[13]  Sarah A. Chau,et al.  Current and Emerging Drug Treatment Options for Alzheimer’s Disease , 2011, Drugs.

[14]  Y. Nagao,et al.  Reinvestigation of the synthesis of isoliquiritigenin: application of Horner-Wadsworth-Emmons reaction and Claisen-Schmidt condensation. , 2011, Chemical & pharmaceutical bulletin.

[15]  S. S. Kalanur,et al.  Interaction of Bioactive Coomassie Brilliant Blue G with Protein: Insights from Spectroscopic Methods , 2010, Scientia pharmaceutica.

[16]  G. Perry,et al.  Oxidative stress in Alzheimer disease: A possibility for prevention , 2010, Neuropharmacology.

[17]  Aamir Nazir,et al.  Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology. , 2010, Journal of medicinal chemistry.

[18]  Y. Ashani,et al.  The Kinetics of Inhibition of Human Acetylcholinesterase and Butyrylcholinesterase by Two Series of Novel Carbamates , 2007, Molecular Pharmacology.

[19]  Xiaoyan Chen,et al.  PHARMACOKINETICS AND METABOLISM OF THE FLAVONOID SCUTELLARIN IN HUMANS AFTER A SINGLE ORAL ADMINISTRATION , 2006, Drug Metabolism and Disposition.

[20]  H. Hong,et al.  Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. , 2004, Life sciences.

[21]  Xudong Huang,et al.  Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology , 2004, Annals of the New York Academy of Sciences.

[22]  Li Di,et al.  High throughput artificial membrane permeability assay for blood-brain barrier. , 2003, European journal of medicinal chemistry.

[23]  C. Geula,et al.  Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.

[24]  M Toth,et al.  Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Kourai,et al.  Studies of the Selective O-Alkylation and Dealkylation of Flavonoids. VII. Partial Dealkylation of 5, 6, 7-Trioxygenated Flavones and Synthesis of Pectolinarigenin and Its Analogues , 1985 .

[26]  M. Huffman,et al.  4',5,6,7-OXYGENATED FLAVONES AND FLAVANONES. , 1964, Journal of pharmaceutical sciences.